Company Information
Product Portfolio
Investors
Partnerships
 
  NEWS  
 
  • May 12, 2007:  Phytopharmacon Strengthens Intellectual Property Position. 
  • The Company has been issued a patent in January 2008 for “Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseases”
  • Another Patent was allowed in September 2007 “Diterpene derivatives for the treatment of cardiovascular, cancer and inflammatory diseases”